Non Interventional Study in Patients With Diagnosis of HCC in Whom a Decision to Treat With Sorafenib Has Not Been Made at Time of Study Enrollment
Observational
Observational Model: Cohort, Time Perspective: Prospective
Determination of 'real-life' practice patterns of physicians involved in the care of patients with HCC (collection of data on treatments prescribed as well as demographic data and data on the entire medical history)
up to 3,3 years
No
Bayer Study Director
Study Director
Bayer
United States: Federal Government
14611
NCT01191385
November 2010
December 2013
Name | Location |
---|---|
Hinsdale, Illinois 60521 | |
Bettendorf, Iowa 52722 | |
Alexandria, Minnesota 56308 | |
Albany, Georgia 31701 | |
Fountain Valley, California 92708 | |
Miami, Florida 33176 | |
Columbia, Missouri 65203 | |
Albany, New York 12208 | |
Philadelphia, Pennsylvania 19104 | |
Austin, Texas 78705 | |
Flint, Michigan 48532 | |
Louisville, Kentucky 40207 | |
McLean, Virginia 22101 | |
Little Rock, Arkansas 72205-7199 | |
Hackensack, New Jersey 07601 | |
Metairie, Louisiana 70006 | |
Denver, Colorado | |
Baltimore, Maryland 21287 | |
Boston, Massachusetts | |
Eugene, Oregon | |
Indianapolis, Indiana | |
Charleston, South Carolina | |
Lebanon, New Hampshire | |
Washington, District of Columbia |